SINOPEP-ALLSINO BIOPHARMACEUTICAL CO LTD
SINOPEP-ALLSINO BIOPHARMACEUTICAL CO LTD (China) holds 24 active US FDA Type II Drug Master Files and 3 inactive, has DMF or CEP filings on record for 20 active ingredients and is linked to 1 FDA-registered manufacturing site. No FDA recall, Warning Letter or Form 483 record is linked to it, which is not proof that none exists.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “SINOPEP-ALLSINO BIOPHARMACEUTICAL CO LTD: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/sinopep-allsino-biopharmaceutical-co-ltd
Overview
SINOPEP-ALLSINO BIOPHARMACEUTICAL CO LTD is an active pharmaceutical ingredient (API) supplier with 23 active FDA Type II Drug Master Files, covering BALOXAVIR MARBOXIL; BIVALIRUDIN; CAGRILINTIDE; CETRORELIX ACETATE; DESMOPRESSIN ACETATE; DMT-2'FLUORO-DA(BZ) AMIDITE.
Core services & business areas
Active ingredients with DMF or CEP filings
Substances for which SINOPEP-ALLSINO BIOPHARMACEUTICAL CO LTD holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.
API / Drug Master Files
SINOPEP-ALLSINO BIOPHARMACEUTICAL CO LTD holds 24 active (27 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.
- DIFELIKEFALIN ACETATEActive2026-09-04
- CAGRILINTIDEActive2026-03-26
- RETATRUTIDEActive2026-03-19
- SEMAGLUTIDE (SEMI-SYNTHETIC)Active2025-12-29
- RISDIPLAM INTERMEDIATE (CAS NO.: 2133298-74-3)Active2025-12-11
- SEMAGLUTIDEActive2025-12-01
- DMT-2'FLUORO-DA(BZ) AMIDITEActive2025-10-29
- ICOTROKINRAActive2025-08-29
- ORFORGLIPRONActive2025-04-27
- BALOXAVIR MARBOXILActive2025-04-18
- ELACESTRANT DIHYDROCHLORIDEActive2025-03-26
- RISDIPLAMActive2024-09-23
- TIRZEPATIDEActive2024-02-06
- DESMOPRESSIN ACETATEActive2023-01-16
- FULVESTRANT INTERMEDIATE (CAS NO.: 875573-66-3)Active2022-09-01
- SEMAGLUTIDEActive2021-11-01
- OSELTAMIVIR INTERMEDIATE (CAS No.: 651324-08-2)Active2021-09-22
- CETRORELIX ACETATEActive2020-09-29
- OSELTAMIVIR PHOSPHATEActive2020-04-30
- FULVESTRANTActive2020-03-26
- LIRAGLUTIDEActive2019-09-19
- BIVALIRUDINActive2018-06-29
- OCTREOTIDE ACETATEActive2017-10-12
- LANREOTIDE ACETATEActive2016-08-16
- BIVALIRUDIN (PROCESS II)Inactive2020-09-30
- LIRAGLUTIDEInactive2018-09-05
- DECOQUINATEInactive2017-02-12
Registered manufacturing sites (1)
Physical sites registered with the US FDA and resolved to SINOPEP-ALLSINO BIOPHARMACEUTICAL CO LTD, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to SINOPEP-ALLSINO BIOPHARMACEUTICAL CO LTD in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.
Is this SINOPEP-ALLSINO BIOPHARMACEUTICAL CO LTD?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Related companies
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.